Keeping tabs on SARS-CoV-2
In the ENDVOC project we will study
variants of concern across the world
Supporting the global response to COVID-19 and future pandemics
We will evaluate the impact of different variants in
diagnostics, treatment, and public health strategies
By investigating the circulation and impact of current and emerging
SARS-CoV-2 variants of concern (VOC), we aim to evaluate and
support effective pandemic responses. To do so, we will use data from
well-established patient and population cohorts across the world.
” Detecting emerging Covid-19 variants of concern, and understanding their
implications on diagnostics, vaccination strategies and treatment options
is key to guiding our response to the virus”
Ibrahim Abubakar, principal researcher of the project based at UCL
ENDVOC in numbers
Our project at a glance
20
Partners
24
Countries
33
Cohorts
5
Key research
questions
What’s new
Keep track of our activities and results
First Encounter with SARS-CoV-2 Shapes Antibody Response to Repeated Vaccination
END-VOC researchers show that the antibody profile evolves with repeated mRNA vaccination, offering new clues about long-term protection against COVID-19 […]
END-VOC’s Legacy
As END-VOC comes to an end, this table summarises the project’s key results, who can use them, what for, and how to access them […]
Being Infected or Vaccinated First Influences COVID-19 Immunity
Using data from a healthcare worker cohort, ENDVOC researchers show that people first vaccinated show stronger antibody responses to Omicron […]
